One group discovered in breast cancer that increased ECM rigidity could activate the EPHA2/LYN/TWIST signaling pathway that promotes the epithelial-to-mesenchymal transition (EMT), and tumor metastasis [76]. Here, EPHA2 is linked to neoplasm.